Long-Term Outcomes of Autologous Transplantation in Multiple Myeloma: Significant Survival Benefit of Novel Drugs in Post-Transplantation Relapse
Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · 436-442
DOI: 10.3816/clm.2009.n.086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphoma and Myeloma, 2009-12. Verfasst von Marta Krejci und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine - Hematooncology, Masaryk University Hospital, Jihlavska 20, 625 00 Brno, Czech Republic. mkrejci@fnbrno.cz. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine - Hematooncology, Masaryk University Hospital, Jihlavska 20, 625 00 Brno, Czech Republic. mkrejci@fnbrno.cz
Zitieren
APA
Krejci, M., Scudla, V., Tothova, E., Schutzova, M., Koza, V., Adam, Z., Krivanova, A., Pour, L., Buchler, T., Sandecka, V., Kralova, D., Zahradova, L., Vorlicek, J., Mayer, J., & Hajek, R. (2009). Long-Term Outcomes of Autologous Transplantation in Multiple Myeloma: Significant Survival Benefit of Novel Drugs in Post-Transplantation Relapse. Clinical Lymphoma and Myeloma, 9(6), 436-442. https://doi.org/10.3816/clm.2009.n.086
Vancouver
Krejci M, Scudla V, Tothova E, Schutzova M, Koza V, Adam Z, et al. Long-Term Outcomes of Autologous Transplantation in Multiple Myeloma: Significant Survival Benefit of Novel Drugs in Post-Transplantation Relapse. Clinical Lymphoma and Myeloma. 2009;9(6):436-442. doi:10.3816/clm.2009.n.086
BibTeX
@article{Krejci2009,
author = {Krejci, Marta and Scudla, Vlastimil and Tothova, Elen and Schutzova, Miroslava and Koza, Vladimir and Adam, Zdenek and Krivanova, Andrea and Pour, Ludek and Buchler, Tomas and Sandecka, Viera and Kralova, Dana and Zahradova, Lenka and Vorlicek, Jiri and Mayer, Jiri and Hajek, Roman},
title = {Long-Term Outcomes of Autologous Transplantation in Multiple Myeloma: Significant Survival Benefit of Novel Drugs in Post-Transplantation Relapse},
journal = {Clinical Lymphoma and Myeloma},
year = {2009},
volume = {9},
number = {6},
pages = {436--442},
doi = {10.3816/clm.2009.n.086}
}
EUVIMED